🔴 Krystal Biotech is trading 4.3% down today as pre-market gains fade

Krystal Biotech is trading at $339.56 (4.3% down) today after a strong pre-market move higher faded during the regular trading session.

• There are no new company-specific headlines, earnings reports, or FDA decisions directly linked to the intraday reversal.
• The broader biotech sector is currently under pressure, suggesting the decline is primarily driven by market sentiment rather than a fundamental shift for the company.
• The move represents a sharp turnaround from early morning momentum, with the stock now tracking lower alongside industry peers.